Patent assignee · US · COMPANY

INTERMUNE, INC.

🏢 View company profile →
52Patents
46Active
52Granted
52Portfolio score

Filing activity: Apr 15, 1983 → Jun 27, 2019 · 22 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7491794B2 Macrocyclic compounds as inhibitors of viral replication Human Necessities 109 Expired
US8119592B2 Compounds and methods for inhibiting hepatitis C viral replication Chemistry; Metallurgy 50 Active
US8299021B2 Macrocyclic inhibitors of hepatitis C virus replication Emerging Cross-Sectional Technologies 45 Active
US7728013B2 Method of modulating stress-activated protein kinase system Emerging Cross-Sectional Technologies 35 Active
US7407973B2 Use of pirfenidone in therapeutic regimens Emerging Cross-Sectional Technologies 27 Expired
US7696236B2 Method of providing pirfenidone therapy to a patient Human Necessities 26 Active
US7767700B2 Method of providing pirfenidone therapy to a patient Human Necessities 20 Active
US7829665B2 Macrocyclic inhibitors of hepatitis C virus replication Emerging Cross-Sectional Technologies 19 Active
US7816383B1 Methods of administering pirfenidone therapy Emerging Cross-Sectional Technologies 18 Active
US8420674B2 Method of providing pirfenidone therapy to a patient Human Necessities 15 Active
US7566729B1 Modifying pirfenidone treatment for patients with atypical liver function Emerging Cross-Sectional Technologies 13 Active
US8741936B2 Method of modulating stress-activated protein kinase system Emerging Cross-Sectional Technologies 11 Active
US9359379B2 Anti-fibrotic pyridinones Chemistry; Metallurgy 11 Active
US9675593B2 Anti-fibrotic pyridinones Chemistry; Metallurgy 9 Active
US7635707B1 Pirfenidone treatment for patients with atypical liver function Emerging Cross-Sectional Technologies 9 Active
US7767225B2 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients Emerging Cross-Sectional Technologies 8 Active
US8084475B2 Pirfenidone therapy and inducers of cytochrome P450 Emerging Cross-Sectional Technologies 7 Active
US8304413B2 Compounds and methods for treating inflammatory and fibrotic disorders Chemistry; Metallurgy 7 Active
US8975235B2 Lysophosphatidic acid receptor antagonists Chemistry; Metallurgy 6 Active
US8013002B2 Methods of administering pirfenidone therapy Emerging Cross-Sectional Technologies 6 Active
US7910610B1 Methods of administering pirfenidone therapy Emerging Cross-Sectional Technologies 6 Active
US7781474B2 Inhibitors of hepatitis C virus replication Chemistry; Metallurgy 6 Active
US9290450B2 Compounds and methods for treating inflammatory and fibrotic disorders Chemistry; Metallurgy 5 Active
US7988994B2 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients Emerging Cross-Sectional Technologies 5 Active
US8383150B2 Granulate formulation of pirfenidone and pharmaceutically acceptable excipients Emerging Cross-Sectional Technologies 4 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.